九强生物(300406.SZ)公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为纤维蛋白(原)降解产物测定试剂盒(胶乳免疫比浊法)，注册证编号为京械注准20262400041，注册类别为Ⅱ类，有效期至2031年2月4日。该试剂盒用于体外定量检测人血浆中的纤维蛋白(原)降解产物(FDP)含量。此注册证的取得丰富了公司在体外诊断血凝细分领域产品线的品种，预计对公司未来的经营产生积极影响，但实际销售情况取决于市场推广效果，公司目前无法预测其对未来业绩的具体影响。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.